Crossmark

Progress of molecular targeted therapy for head and neck cancer in clinical aspects

Crossref DOI link: https://doi.org/10.1186/s43556-021-00032-5

Published Online: 2021-05-30

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nakano, Kenji https://orcid.org/0000-0002-3721-004X
License Information

Text and Data Mining valid from 2021-05-30

Version of Record valid from 2021-05-30
More Information

Article History

Received: 27 October 2020

Accepted: 1 March 2021

First Online: 30 May 2021

Declarations

:

: Not applicable.

: Not applicable.

: None to declare.